Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2335 (114th)

Stop Tampering of Prescription Pills Act of 2015

referredUnited States· United States Congress· EN

Introduced

14 May 2015

Last action

15 May 2015 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Keating, William R. [D-MA-9], Rep. Rogers, Harold [R-KY-5], Rep. Rooney, Thomas J. [R-FL-17], Rep. Lynch, Stephen F. [D-MA-8], Rep. Aderholt, Robert B. [R-AL-4], Rep. Buchanan, Vern [R-FL-16], Rep. Kennedy, Joseph P., III [D-MA-4], Rep. McGovern, James P. [D-MA-2], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Clark, Katherine M. [D-MA-5]

Subjects

Healthcare

Source updated

12 August 2025

Healthcare

Summary

Stop Tampering of Prescription Pills Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to deny approval to a new oral opioid (a drug with effects similar to opium, such as morphine) that does not have properties that make the drug significantly more difficult to abuse if an abuse-deterrent drug containing the same opioid is available. The FDA may approve an opioid drug that is not abuse-deterrent if approval is necessary to prevent or alleviate a drug shortage or to address a significant unmet public health need. To be approved by the FDA, a generic version of an abuse-deterrent brand name drug must be at least comparably abuse-deterrent and its active components must not differ in any material respect from the brand name drug. An approved generic drug is not bioequivalent to, and does not have the same therapeutic effect as, a brand name drug that becomes abuse-deterrent unless the generic drug is at least comparably abuse-deterrent. Approval of a generic oral opioid is withdrawn if the brand name drug is not abuse-deterrent and not available and there is an approved abuse-deterrent drug available that contains the same opioid in the same dose. Approval of an oral opioid is withdrawn if the drug is not abuse-deterrent and there is an approved abuse-deterrent drug available that contains the same opioid. Withdrawal of approval may be waived by the FDA for a drug intended for a special needs population. The FDA must delay withdrawal to give the drug sponsor an opportunity to obtain approval for an abuse-deterrent formulation of the drug.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 14 May 2015

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 14 May 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 14 May 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 15 May 2015

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 14 May 2015

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 14 May 2015

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 14 May 2015

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.